Literature DB >> 21080077

A novel human derived cell-penetrating peptide in drug delivery.

Jian Zhao1, Peng Gao, Wei Xiao, Li-Qiang Fan, Fu-Jun Wang, Su-Xia Li, Jian-Wen Liu.   

Abstract

Cell-penetrating peptides can carry a variety of biologically active molecules into cells. Here we have identified a novel CPP derived from the C-terminus of human extracellular superoxide dismutase (hC-SOD3) which was shown to be located throughout in the cytoplasm and nucleus by fluorescence microscopy investigation. Furthermore, when apoptin fused to hC-SOD3, it was translocated efficiently into HeLa cells resulting in antitumor activities. This study shows that hC-SOD3 has the potential to penetrate and translocate cargo molecules into cells and has no cytotoxicity at effective concentration.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21080077     DOI: 10.1007/s11033-010-0406-6

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  19 in total

Review 1.  Cell penetrating peptides in drug delivery.

Authors:  Eric L Snyder; Steven F Dowdy
Journal:  Pharm Res       Date:  2004-03       Impact factor: 4.200

Review 2.  Cell penetrating peptides: intracellular pathways and pharmaceutical perspectives.

Authors:  Leena N Patel; Jennica L Zaro; Wei-Chiang Shen
Journal:  Pharm Res       Date:  2007-04-19       Impact factor: 4.200

3.  Characterization of the heparin-binding domain of human extracellular superoxide dismutase.

Authors:  L A Tibell; I Sethson; A V Buevich
Journal:  Biochim Biophys Acta       Date:  1997-06-20

4.  Synthetic protein transduction domains: enhanced transduction potential in vitro and in vivo.

Authors:  A Ho; S R Schwarze; S J Mermelstein; G Waksman; S F Dowdy
Journal:  Cancer Res       Date:  2001-01-15       Impact factor: 12.701

5.  Synthesis and anti-inflammatory activity of a chimeric recombinant superoxide dismutase: SOD2/3.

Authors:  Bifeng Gao; Sonia C Flores; Jonathan A Leff; Swapan K Bose; Joe M McCord
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2003-01-10       Impact factor: 5.464

Review 6.  Extracellular superoxide dismutase (ecSOD) in vascular biology: an update on exogenous gene transfer and endogenous regulators of ecSOD.

Authors:  Zhenyu Qin; Krzysztof J Reszka; Tohru Fukai; Neal L Weintraub
Journal:  Transl Res       Date:  2007-11-08       Impact factor: 7.012

7.  Nuclear translocation of extracellular superoxide dismutase.

Authors:  Tomomi Ookawara; Takako Kizaki; Eiji Takayama; Nobuo Imazeki; Osamu Matsubara; Yoshitaka Ikeda; Keiichiro Suzuki; Li Li Ji; Takushi Tadakuma; Naoyuki Taniguchi; Hideki Ohno
Journal:  Biochem Biophys Res Commun       Date:  2002-08-09       Impact factor: 3.575

8.  Simultaneous expression of recombinant baculovirus-encoded chicken anaemia virus (CAV) proteins VP1 and VP2 is required for formation of the CAV-specific neutralizing epitope.

Authors:  M H Noteborn; C A Verschueren; G Koch; A J Van der Eb
Journal:  J Gen Virol       Date:  1998-12       Impact factor: 3.891

9.  The high concentration of Arg213-->Gly extracellular superoxide dismutase (EC-SOD) in plasma is caused by a reduction of both heparin and collagen affinities.

Authors:  Steen V Petersen; Dorte Aa Olsen; John M Kenney; Tim D Oury; Zuzana Valnickova; Ida B Thøgersen; James D Crapo; Jan J Enghild
Journal:  Biochem J       Date:  2005-01-15       Impact factor: 3.857

Review 10.  Apoptin: therapeutic potential of an early sensor of carcinogenic transformation.

Authors:  Claude Backendorf; Astrid E Visser; A G de Boer; Rhyenne Zimmerman; Mijke Visser; Patrick Voskamp; Ying-Hui Zhang; Mathieu Noteborn
Journal:  Annu Rev Pharmacol Toxicol       Date:  2008       Impact factor: 13.820

View more
  5 in total

Review 1.  Extracellular superoxide dismutase and its role in cancer.

Authors:  Brandon Griess; Eric Tom; Frederick Domann; Melissa Teoh-Fitzgerald
Journal:  Free Radic Biol Med       Date:  2017-08-24       Impact factor: 7.376

2.  A truncated apoptin protein variant selectively kills cancer cells.

Authors:  Santiago Ruiz-Martínez; Jessica Castro; Maria Vilanova; Marta Bruix; Douglas V Laurents; Marc Ribó; Antoni Benito
Journal:  Invest New Drugs       Date:  2017-01-24       Impact factor: 3.850

3.  Identification of a novel cell-penetrating peptide from human phosphatidate phosphatase LPIN3.

Authors:  Sangho Lim; Won-ju Kim; Yeon-ho Kim; Je-Min Choi
Journal:  Mol Cells       Date:  2012-12-13       Impact factor: 5.034

4.  Secretory TAT-peptide-mediated protein transduction of LIF receptor α-chain distal cytoplasmic motifs into human myeloid HL-60 cells.

Authors:  Q Sun; J Xiong; J Lu; S Xu; Y Li; X P Zhong; G K Gao; H Q Liu
Journal:  Braz J Med Biol Res       Date:  2012-06-21       Impact factor: 2.590

5.  LXXLL peptide converts transportan 10 to a potent inducer of apoptosis in breast cancer cells.

Authors:  Kairit Tints; Madis Prink; Toomas Neuman; Kaia Palm
Journal:  Int J Mol Sci       Date:  2014-04-03       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.